High proportions of rectal and pharyngeal chlamydia and gonorrhoea cases among cisgender men are missed using current CDC screening recommendations

Objectives Pharyngeal and rectal Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are often undiagnosed due to their asymptomatic nature. This study aims to determine (1) the prevalence of CT/NG infections by anatomical site among cisgender men; (2) the proportion of missed CT/NG rectal/pharyngeal infections if urogenital testing alone was performed or screening depended on self-reported behaviour alone; and (3) the predictive probability of self-reported behaviours for rectal CT/NG. Methods This cross-sectional study used electronic health records collected at a sexual health clinic in Los Angeles from 18 November 2018 until 28 February 2020. The included patients were ≥18 years of age cisgender men who received CT/NG testing at least once during the study period. We calculated the proportion of missed pharyngeal/rectal CT/NG infections if only urogenital testing had been done and if testing was based only on self-reported anal sex. Separately, we ran logistic regressions for predictive probability of self-reported anal sex on CT/NG rectal infections. Results Overall, there were 13 476 unique patients with 26 579 visits. The prevalence of any extragenital CT/NG infection was 37.28%. Over 80% rectal/pharyngeal CT cases and over 65% rectal/pharyngeal NG cases would be missed if urogenital testing alone was performed. Likewise, over 35% rectal CT/NG cases would be missed had testing relied on self-reported sexual behaviours alone. Conclusions The proportion of missed rectal and pharyngeal CT/NG infections is high. Our data from a sexual health clinic lend support to three-site opt-out testing for cisgender men attending a sexual health/Lesbian, Gay, Bisexual, Transgender, Queer/Questioning (LGBTQ+) specialty clinic regardless of their sexual orientation or reported sexual behaviours.

[1]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season , 2021, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[2]  K. Workowski,et al.  Sexually Transmitted Infections Treatment Guidelines, 2021 , 2021, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  J. Salomon,et al.  Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States , 2021, Sexually transmitted diseases.

[4]  Elizabeth A Torrone,et al.  Extragenital Gonorrhea and Chlamydia Positivity and the Potential for Missed Extragenital Gonorrhea With Concurrent Urethral Chlamydia Among Men Who Have Sex With Men Attending Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, 2015-2019. , 2020, Sexually transmitted diseases.

[5]  J. Salomon,et al.  Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis , 2020, Sexually transmitted diseases.

[6]  K. Workowski,et al.  Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  R. Kirkcaldy,et al.  Epidemiology of gonorrhoea: a global perspective. , 2019, Sexual health.

[8]  P. Phanuphak,et al.  Correlations of chlamydia and gonorrhoea among pharyngeal, rectal and urethral sites among Thai men who have sex with men: multicentre community-led test and treat cohort in Thailand , 2019, BMJ Open.

[9]  Michelle Jones.  Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending Men Who Have Sex with Men — Five Cities, United States, 2017 , 2019 .

[10]  P. Sullivan,et al.  Proportion of Incident Human Immunodeficiency Virus Cases Among Men Who Have Sex With Men Attributable to Gonorrhea and Chlamydia: A Modeling Analysis. , 2019, Sexually transmitted diseases.

[11]  D. Dowdy,et al.  Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model , 2018, Sexually transmitted diseases.

[12]  R. Bolan,et al.  Using Sexual Orientation and Gender Identity to Monitor Disparities in HIV, Sexually Transmitted Infections, and Viral Hepatitis , 2018, American journal of public health.

[13]  R. Gandhi.  Preexposure Prophylaxis for the Prevention of HIV , 2018 .

[14]  Christina C. Chang,et al.  Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Law,et al.  Concordance of gonorrhoea of the rectum, pharynx and urethra in same-sex male partnerships attending a sexual health service in Melbourne, Australia , 2018, BMC Infectious Diseases.

[16]  K. Chapin,et al.  Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature , 2016, Infectious diseases in obstetrics and gynecology.

[17]  G. Anschuetz,et al.  Extragenital Screening in Men Who Have Sex With Men Diagnoses More Chlamydia and Gonorrhea Cases Than Urine Testing Alone. , 2016, Sexually transmitted diseases.

[18]  A. R. Lutz.  Screening for Asymptomatic Extragenital Gonorrhea and Chlamydia in Men Who Have Sex with Men: Significance, Recommendations, and Options for Overcoming Barriers to Testing. , 2015, LGBT health.

[19]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[20]  R. Kirkcaldy,et al.  Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  W. Jenkins,et al.  Cross-sectional study of pharyngeal and genital chlamydia and gonorrhoea infections in emergency department patients , 2013, Sexually Transmitted Infections.

[22]  S. Braunstein,et al.  HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  C. Hoebe,et al.  Standard Symptom- and Sexual History–Based Testing Misses Anorectal Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Swingers and Men Who Have Sex With Men , 2013, Sexually transmitted diseases.

[24]  Mckinley Health Center.  Chlamydia and Gonorrhea. , 2013, Journal of midwifery & women's health.

[25]  C. Hoebe,et al.  The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006–2010 , 2012, International journal of STD & AIDS.

[26]  Amy M. Sitapati,et al.  Denial of Risk Behavior Does Not Exclude Asymptomatic Anorectal Sexually Transmitted Infection in HIV-Infected Men , 2009, PloS one.

[27]  K. Workowski,et al.  Pharyngeal gonorrhea: an important reservoir of infection? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  N. T. Annan,et al.  Rectal chlamydia—a reservoir of undiagnosed infection in men who have sex with men , 2009, Sexually Transmitted Infections.

[29]  D. Fleming,et al.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.

[30]  Myron S. Cohen,et al.  Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis , 1998, The Lancet.